Jeffrey A. Sloan

Mayo Clinic — United States

Medicine · Health Sciences

28h-index4.5kcitations86works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer survivorship and care(16), Health Systems, Economic Evaluations, Quality of Life(12), Cancer Treatment and Pharmacology(9), Palliative Care and End-of-Life Issues(8), Head and Neck Cancer Studies(6)

Publications85 total

Health‐related quality of life outcomes for the LEAP study—CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients
Cancer·2020· 17 citedOpen Access
A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)
Cancer·2020· 31 citedOpen Access
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)
The Oncologist·2019· 21 citedOpen Access
A Personalized Decision Aid to Help Women with Lupus Nephritis from Racially and Ethnically Diverse Backgrounds Make Decisions about Taking Immune-Blocking Medicines
2019· 1 cited
Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study
The Lancet Oncology·2019· 270 citedOpen Access
THU0651 AN INDIVIDUALIZED DECISION-AID FOR DIVERSE WOMEN WITH LUPUS NEPHRITIS (IDEA-WON): A RANDOMIZED CONTROLLED TRIAL
Annals of the Rheumatic Diseases·2019· 1 citedOpen Access
Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial
PLoS Medicine·2019· 45 citedOpen Access
Regorafenib Dose-Optimization Study (ReDOS): A Phase 2 Randomized Study to Evaluate Dosing Strategies for Regorafenib in Patients with Refractory Metastatic Colorectal Cancer - An ACCRU Network Study
SSRN Electronic Journal·2019Open Access
The impact of a renal support care service on symptom control, advance care planning and place of death for patients with advanced chronic kidney disease managed without dialysis
2019
Patient-reported outcomes, emoji, and activity measured on the Apple Watch in cancer patients.
Journal of Clinical Oncology·2018· 12 cited
Regorafenib dose optimization study (ReDOS): Randomized phase II trial to evaluate dosing strategies for regorafenib in refractory metastatic colorectal cancer (mCRC)–An ACCRU Network study.
Journal of Clinical Oncology·2018· 37 cited
Patient and Provider Perceptions of Real-Time Quality of Life Measures During Head and Neck Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics·2017Open Access
Prevention of lymphedema in women with breast cancer (BC): Results of CALGB (Alliance) 70305.
Journal of Clinical Oncology·2017· 2 cited
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis
American Journal of Hematology·2017· 23 citedOpen Access
A patient-reported outcome driven case management system for hematology/oncology patients.
Journal of Clinical Oncology·2016
Patient-reported outcome driven case management system for hematology and oncology patients.
Journal of Clinical Oncology·2016
Quality of Life Analysis of a Radiation Dose–Escalation Study of Patients With Non–Small-Cell Lung Cancer
JAMA Oncology·2015· 177 citedOpen Access
Clinical Significance
Wiley StatsRef: Statistics Reference Online·2014· 2 cited
Clinical Significance
2014· 2 cited
Application of a novel socioeconomic measure using individual housing data in asthma research: an exploratory study
npj Primary Care Respiratory Medicine·2014· 46 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Lesley F. Degner(6), Charles L. Loprinzi(6), Pamela J. Atherton(5), Charles Erlichman(5), Tait D. Shanafelt(4), Andrea Cheville(4), Ayalew Tefferi(4), Yolanda I. Garces(4), Paul J. Novotny(4), Daniel J. Sargent(4), Ruben A. Mesa(3), Joyce Niblack(3), Mark R. Litzow(3), John Camoriano(3), Srđan Verstovšek(3), Evanthia Galanis(3), Aminah Jatoi(3), Matthew M. Ames(3), Alex A. Adjei(3), Jasvinder A. Singh(3)